Marilaine Mota-Meira

Title: Marilaine Mota-Meira: Innovator in Antibacterial Research

Introduction

Marilaine Mota-Meira is a notable inventor based in Loretteville, Canada. He has made significant contributions to the field of antibacterial research, particularly through his work on lantibiotics. With a total of two patents to his name, Mota-Meira's innovations focus on the purification and application of bactericidal substances.

Latest Patents

Mota-Meira's latest patents include "Lantibiotic from Streptococcus mutans, method of production and use thereof" and "Lantibiotic from Streptococcus mutans and uses thereof." These patents detail the production of mutacin, a bactericidal substance produced by lantibiotics, which contain post-translationally modified amino acids such as lanthionine. The inventions describe a straightforward method for purifying mutacin B-Ny266 from strain Ny266 to homogeneity. Additionally, they provide insights into the primary amino acid sequence of mutacin B-Ny266 and its proposed modified structure. The patents also outline compositions that include mutacin B-Ny266 and methods for treating or preventing bacterial infections through the administration of suitable doses of these compositions.

Career Highlights

Mota-Meira is affiliated with Université Laval, where he conducts his research and development in antibacterial substances. His work has garnered attention for its potential applications in medical treatments, particularly in combating bacterial infections.

Collaborations

Some of Mota-Meira's notable coworkers include Marc Lavoie and Christophe Lacroix. Their collaborative efforts contribute to the advancement of research in the field of antibacterial agents.

Conclusion

Marilaine Mota-Meira's contributions to antibacterial research through his patents on lantibiotics highlight his innovative approach to addressing bacterial infections. His work at Université Laval continues to pave the way for advancements in medical treatments.